Research Team

Present

Anna Bonvissuto-Pin

Anna Bonvissuto-Pin

Lab Manager

Biography: Anna received her MSc from Anatomy and Cell Biology at Western. She has worked in research at McGill University, Purdue University and at Victoria Research Labs. She keeps the lab running smoothly, the trainees happy and Dr. Parsyan on track.
Verspeeten Family Cancer Centre, A4-903
519-685-6500 ext 53271
apin@uwo.ca

External link
Anayra Goncalves

Anayra Goncalves

PhD student

Research Interests / Specializations: Breast cancer, spatial omics, metastasis, chemoresistance
Biography: Anayra Goncalves is a PhD student from Brazil. She is using spatial omics to identify new biomarkers linked to metastasis of triple-negative breast cancer (TNBC) to the axillary lymph nodes and its resistance to chemotherapy. Outside of the lab, she enjoys reading, watching TV shows, singing, and playing the ukulele.
Isabel Kannampuzha

Isabel Kannampuzha

MSc student

Research Interests / Specializations: Combination therapy, metastasis, chemoresistance, organoid models, gene expression
Biography: Isabel is currently completing a Bachelor of Medical Sciences with an Honours Specialization in Biochemistry. She is working to further investigate differential gene expression under PLK4 inhibition and radiotherapy conditions

Past

Vasudeva (Vasu) Bhat

Vasudeva (Vasu) Bhat

Former PDF/ Research Associate

Research Interests / Specializations: Breast cancer, cancer stem cells, metastasis, lung microenvironment, tumor-immune microenvironment, liquid biopsy, organoid models, spatial omics
Biography: Dr. Vasudeva (Vasu) Bhat received his PhD from University of Manitoba. He completed postdoctoral training, funded by Breast Cancer Canada and Western University, followed by a position as Adjunct Research Professor at Western University.
Harjot Kaur Athwal

Harjot Kaur Athwal

Former graduate student (MSc)

Biography: Harjot Athwal completed her MSc. in Anatomy and Cell Biology, supervised by Dr. Parsyan, investigating the combination treatment of PLK4 inhibitor, CFI-400945, with radiotherapy in triple negative breast cancer. She now works as an Associate Scientist with the biotech company, ProteinQure, located in Toronto, ON, Canada
Sierra Pellizzari

Sierra Pellizzari

Former graduate student (MSc)

Biography: Sierra Pellizzari completed her MSc. in Anatomy and Cell Biology, supervised by Dr. Parsyan and Dr. Allan, investigating the anticancer effects of a combination of novel drug CFI-400945 and radiation in triple negative breast cancer. She is currently in medical school at Queen's University, Kingston, ON, Canada.